SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 206.01-0.4%Nov 19 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Henry Niman who wrote (22494)6/18/1998 9:38:00 PM
From: Machaon  Read Replies (1) of 32384
 
There's about 316 new drugs being developed to fight cancer.

That is a LOT of competition for LGND. Perhaps this is why the market isn't willing to give LGND a higher value than about $500 million.

You've quoted an analyst that predicts about $14 per share in 2006. But, with over 300 new cancer drugs, being developed, some of which will become big winners, doesn't that diminish LGND's future earnings capabilities?

Regards, Bob
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext